US companies particularly exposed to Japan could see a material impact to earnings from the disaster disproportionate to the average stock. US traded luxury retailers like Tiffany (TIF) and Coach (COH) and insurers MetLife (MET), Aflac (AFL), Prudential (PRU) and Hartford Financial (HIG) all have significant exposure in Japan.
Hartford Financial has legacy variable annuities with guaranteed benefits that would be adversely impacted if the Nikkei index suffers a severe long term downturn. Additionally, a weaker yen versus the dollar would adversely impact yen-dominated earnings while a stronger yen hurts risk based capital ratios. As a result, HIG has been the biggest decliner in the KBW Insurance Index since the Japanese earthquake...
Japan’s nuclear crisis, although still unfolding, has made electricity prices extremely volatile and has caused review and re-assessment of existing plants and nuclear construction projects currently under development. A massive sell-off in virtually all things nuclear has occurred. The crisis is impacting the major USA utilities involved in operating and building nuclear facilities.
US companies, Southern Company (SO) and SCANA Corp. (SCG), currently building nuclear facilities as well as Entergy (ETR), PG&E (PCG) and Edison (EIX) have much at stake both in the short and long term.
Nuclear power now contributes nearly 22 percent of US electricity production and with climbing demand, it is all but impossible to remove all of this power from the market at once.
Will any of these major nuclear players remain a compelling investment idea?...
Japan’s Disaster: Impact on Medical Technology Stocks.
APRIL 1 2011
As Japan, the third-largest economy in the world, struggles to cope with and attempt to recover from the largest catastrophe ever in the island nation’s recorded history, its impact on the medical devices industry may be substantial. Japan represents about 45% of the Asia-Pacific medical devices industry and at about $25 billion, is the second largest market for medical devices in the world.
Japan’s aging demographics are the catalyst for demand of medical devices and the need for advanced medical technology from the west is significant. U.S. firms account for roughly 60% of all imported medical devices products in Japan. The largest exporters include Johnson and Johnson (JNJ), Boston Scientific (BSX) and Medtronic (MDT).
Additionally, St. Jude (STJ), Abbott Laboratories (ABT), and Stryker (SYK) derive hundreds of millions and billions in revenue from Japan. These firms provide leading edge medical products including pacemakers, stents, orthopedic implants, catheters and diagnostic imaging equipment...